0001140361-24-016591.txt : 20240329 0001140361-24-016591.hdr.sgml : 20240329 20240329160544 ACCESSION NUMBER: 0001140361-24-016591 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240327 FILED AS OF DATE: 20240329 DATE AS OF CHANGE: 20240329 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZERBE ROBERT L MD CENTRAL INDEX KEY: 0001220363 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35280 FILM NUMBER: 24804153 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vericel Corp CENTRAL INDEX KEY: 0000887359 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943096597 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 7349305555 MAIL ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC DATE OF NAME CHANGE: 19960428 4 1 form4.xml FORM 4 X0508 4 2024-03-27 0000887359 Vericel Corp VCEL 0001220363 ZERBE ROBERT L MD C/O VERICEL CORPORATION 64 SIDNEY STREET CAMBRIDGE MA 02139 true true Common Stock 2024-03-27 4 M 0 3278 3.74 A 26673 D Common Stock 2024-03-27 4 S 0 3278 51.57 D 23395 D Stock Option (Right to Buy) 3.74 2024-03-27 4 M 0 3278 0 A Common Stock 3278 0 D The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. These options, representing the right to purchase 4,000 shares, became exercisable in three installments, contingent upon continued service to the Company, with the first vesting date on March 20, 2015, which was the date on which the option was granted, and the final vesting date on May 1, 2015. These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025. /s/ Sean Flynn, as Attorney-in-Fact for Robert Zerbe 2024-03-29